Literature DB >> 518627

Adenylate deaminase: potent inhibition by 2'-deoxycoformycin 5'-phosphate.

C Frieden, H R Gilbert, W H Miller, R L Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 518627     DOI： 10.1016/0006-291x(79)90614-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  5 in total

1.  Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.

Authors:  M B Faletto; W H Miller; E P Garvey; M H St Clair; S M Daluge; S S Good
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 2.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.

Authors:  J F Smyth; R M Paine; A L Jackman; K R Harrap; M M Chassin; R H Adamson; D G Johns
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  The pathway of adenine nucleotide catabolism and its control in isolated rat hepatocytes subjected to anoxia.

Authors:  M F Vincent; G Van den Berghe; H G Hers
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

Review 5.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.